Tan, F.H.; Putoczki, T.L.; Lou, J.; Hinde, E.; Hollande, F.; Giraud, J.; Stylli, S.S.; Paradiso, L.; Zhu, H.-J.; Sieber, O.M.;
et al. Ponatinib Inhibits Multiple Signaling Pathways Involved in STAT3 Signaling and Attenuates Colorectal Tumor Growth. Cancers 2018, 10, 526.
https://doi.org/10.3390/cancers10120526
AMA Style
Tan FH, Putoczki TL, Lou J, Hinde E, Hollande F, Giraud J, Stylli SS, Paradiso L, Zhu H-J, Sieber OM,
et al. Ponatinib Inhibits Multiple Signaling Pathways Involved in STAT3 Signaling and Attenuates Colorectal Tumor Growth. Cancers. 2018; 10(12):526.
https://doi.org/10.3390/cancers10120526
Chicago/Turabian Style
Tan, Fiona H., Tracy L. Putoczki, Jieqiong Lou, Elizabeth Hinde, Frédéric Hollande, Julie Giraud, Stanley S. Stylli, Lucia Paradiso, Hong-Jian Zhu, Oliver M. Sieber,
and et al. 2018. "Ponatinib Inhibits Multiple Signaling Pathways Involved in STAT3 Signaling and Attenuates Colorectal Tumor Growth" Cancers 10, no. 12: 526.
https://doi.org/10.3390/cancers10120526
APA Style
Tan, F. H., Putoczki, T. L., Lou, J., Hinde, E., Hollande, F., Giraud, J., Stylli, S. S., Paradiso, L., Zhu, H.-J., Sieber, O. M., & Luwor, R. B.
(2018). Ponatinib Inhibits Multiple Signaling Pathways Involved in STAT3 Signaling and Attenuates Colorectal Tumor Growth. Cancers, 10(12), 526.
https://doi.org/10.3390/cancers10120526